Resources

Cancer immunotherapy is now established as a promising way to treat cancer with the clinical success of therapeutics targeting immune checkpoints. As the field rapidly evolves, tremendous interesthas been generated in the identification of novel immunotherapeutic targets and the development of biomarkers to guide the use of immunotherapies in the most appropriate patients. Creative Biolabs has established the SuPrecision™ platform to offer accurate and high-throughput sequencing services. With years of experience in NGS field, we provide a great deal of useful data in the clinical diagnosis of many diseases, especially cancers.